During the assessment of cell-mediated immunity (CMI) in subjects participating in a large-scale influenza vaccine trial, we identified the expansion of an IFN-γ-producing CD3+CD4−CD8−γδ+T cell population in the peripheral blood of 90/610 (15%) healthy subjects. Here, IFNG is linked to influenza.